K-v Pharmaceutical Cl A (KV-A) Income Statement

Click line-items for a historical chart and %

Net revenues	5.1M
Cost of sales	200K
Gross profit	4.9M
Research and development	5.5M
Selling and administrative	25.7M
Total operating expenses	31.2M
Operating loss	-26.3M
Change in warrant liability
Interest expense	10M
Interest and other (income) expense	-900K
Total other (income) expenses, net	9.7M
Income (loss) from continuing operations before income taxes	-36M
Income tax provision	1.8M
Net income (loss) from continuing operations	-37.8M
Net income (loss) from discontinued operations (net taxes of $- and $(5.2))	0
Gain on sale of discontinued operations (net taxes of $- and $7.4)	0
Net income (loss)	-37.8M
Net income (loss) from continuing operations per share
Net income (loss) from discontinued operations per share
Gain on sale of discontinued operations per share	0
Net income (loss) per share
Net income (loss) from continuing operations per share
Net income (loss) from discontinued operations per share
Gain on sale of discontinued operations per share
Net income (loss) per share
Weighted average shares used in per share calculation:
Basic shares outstanding - Class A common	48.7M
Diluted shares outstanding - Class A common	59.9M
Weighted average shares used in per share calculation:
Basic and diluted shares outstanding - Class B common	11.2M

Entities mentioned with KV-A

View All Entities